Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-12-04 to 2024-12-05
Current total value of award: $2973.05
Description: 4566613920!QUILLIVANT XR 25 MG/5 ML SUSP 120ML